Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITOC: Induction Treatments for HIV-associated Cryptococcal Meningitis
NCT04072640Phase 1Unknown
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jan 2021
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of voriconazole in cryptococcal meningitis (3 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: 90-day Cryptococcal Meningitis related mortality. Status: unknown.
02
Drugs
voriconazole
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT04072640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04072640.